Skip to main content
Clinical Trials/NL-OMON33986
NL-OMON33986
Completed
Not Applicable

Medication induced blood pressure reduction; assessment of cerebral perfusion and cognition in hypertensive elderly - MBRACE

niversitair Medisch Centrum Sint Radboud0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
high blood pressure
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • Systolic hypertension grade II\-III ( Systolic BP \>\=160mmHg) as measured according to JNC\-7 protocol

Exclusion Criteria

  • Systolic blood pressure \>220mmHg
  • Indication for urgent treatment of HT
  • Contra\-indication for MRI including claustrophobia
  • Contra\-indication for anti\-hypertensive medication used (Chlorthalidone, Amlodipine, Valsartan)
  • Renal failure requiring dialysis
  • Atrial fibrillation
  • A life expectancy of less than a year
  • Disabling stroke
  • Impairment by any cause prohibiting participation as mentioned by the general practitioner
  • Diabetes Mellitus

Outcomes

Primary Outcomes

Not specified

Similar Trials